Acid amide

Also found in: Encyclopedia, Wikipedia.
a neutral compound formed by the substitution of the amido group for hydroxyl in an acid.

See also: Amide

References in periodicals archive ?
9-tetrahydracannabinol, or THC) is the psychoactive molecule in the cannabis plant; palmitoylethanolamide (PEA) is an endogenous fatty acid amide that belongs to the class of nuclear factor agonists, which are proteins that regulate the expression of genes.
Lastly, Thors et al studied the expression of the endocannabinoid-metabolizing enzyme fatty acid amide hydrolase from patients diagnosed with prostate cancer.
A new paper in Biological Psychiatry reports that chronic cannabis users have reduced levels of an enzyme called fatty acid amide hydrolase (FAAH).
Global Markets Direct's, 'Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.
Behenamide is an unsaturated long-chain carboxylic acid amide derived from behenic acid.
The study that tested a fatty acid amide hydrolase inhibitor in osteoarthritis patients was stopped early because of futility.
Upon completion of this restructuring, Infinity reacquires worldwide rights for its phosphoinositide-3-kinase (PI3K) programme, its fatty acid amide hydrolase (FAAH) programme and its early discovery programmes.
The common thread in their studies is a gene, which encodes the enzyme called fatty acid amide hydrolase, or FAAH.
Completing a Phase 1 clinical study of IPI-940, the company's novel inhibitor of fatty acid amide hydrolase; * Reporting results from the Phase 2 clinical study of IPI-504, a novel Hsp90 chaperone inhibitor, in patients with non-small cell lung cancer and initiating further clinical development of IPI-504 in this disease;
In January 2016, a Phase I trial in France lead to one death and five cases of hospitalisation within trial participants, representing the most serious case of a trial failure on European soil in the last 10 years and will cast doubt on the safety of the entire class of fatty acid amide hydrolase inhibitor therapeutics, raise doubts over the safety of current procedures and make recruitment for EU trials more difficult in the short term.